{
  "meta": {
    "timestamp": "2025-01-06T07:53:27.966229",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Goodrx Holdings Inc",
      "symbol": "GDRX",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Regulatory and legal risks, including FTC enforcement action and data privacy concerns",
            "Revenue volatility and earnings miss",
            "Dependence on advertising revenue",
            "Competitive pressures from other digital health platforms",
            "Operational dependencies on partnerships with pharmacies and PBMs"
          ],
          "controversies": [
            "FTC enforcement action for unauthorized sharing of personal health information",
            "Data privacy concerns due to reliance on user data for advertising"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Data privacy and consumer trust issues"
          ],
          "governance_issues": [
            "Regulatory scrutiny and potential legal liabilities related to data privacy"
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "GoodRx Holdings, Inc. | Federal Trade Commission",
              "snippet": "The Federal Trade Commission has taken enforcement action for the first time under its Health Breach Notification Rule against the telehealth and prescription drug discount provider GoodRx Holdings Inc., for failing to notify consumers and others of its unauthorized disclosures of consumers' personal health information to Facebook, Google, and other companies.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417782+00:00",
              "published_date": null,
              "source_hash": "9b8cfdbb02236333ae5b5350ff5b3ea5"
            },
            {
              "url": "",
              "title": "FTC Enforcement Action to Bar GoodRx from Sharing Consumers' Sensitive ...",
              "snippet": "The Federal Trade Commission has taken enforcement action for the first time under its Health Breach Notification Rule against the telehealth and prescription drug discount provider GoodRx Holdings Inc., for failing to notify consumers and others of its unauthorized disclosures of consumers' personal health information to Facebook, Google, and other companies.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417772+00:00",
              "published_date": null,
              "source_hash": "3bce21cb317b92057a6b9326ab5ff0dc"
            },
            {
              "url": "",
              "title": "Hold Rating on GoodRx Holdings Amid Challenges and Opportunities",
              "snippet": "In a report released on November 7, Vikram Kesavabhotla from Robert W. Baird maintained a Hold rating on GoodRx Holdings (GDRX - Research Report), with a price target of $7.00.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543362+00:00",
              "published_date": null,
              "source_hash": "8fd445e904695eb031a3cc9eb04b1a15"
            },
            {
              "url": "",
              "title": "Sell Rating Maintained for GoodRx Holdings Amid Volatility and ...",
              "snippet": "In a report released yesterday, Allen Lutz from Bank of America Securities maintained a Sell rating on GoodRx Holdings (GDRX - Research Report), with a price target of $4.50. Discover top-rated ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543367+00:00",
              "published_date": null,
              "source_hash": "9cbcfa358b3c6673ad80549db401eeb1"
            },
            {
              "url": "",
              "title": "FTC issues fine to GoodRx over information sharing",
              "snippet": "The Complaint alleges a nationwide class of \"All natural persons in the United States who used the GoodRx Platform and whose communications and/or data were shared with third parties, including the Advertising and Analytics Defendants.\" [1] Doe v. GoodRx Holdings, Inc., et. al, 3:23-cv-00501-LB (N.D. Cal.). Related People",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417797+00:00",
              "published_date": null,
              "source_hash": "cb2c723370f0c0064cee2caf90c61a0a"
            },
            {
              "url": "",
              "title": "Buy Rating for GoodRx Holdings Amid FTC Scrutiny and Strategic Market ...",
              "snippet": "Consequently, Berenshteyn recommends buying GoodRx Holdings' stock, especially during the current price dip, as a strategic investment decision. See the top stocks recommended by analysts >>",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543377+00:00",
              "published_date": null,
              "source_hash": "2f9440d8bb4b43132cad1fb6215b0634"
            },
            {
              "url": "",
              "title": "Federal Trade Commission's GoodRx Settlement: Not Just a $1.5 Million ...",
              "snippet": "The Federal Trade Commission (FTC) recently kicked off enforcement of its Health Breach Notification Rule (Breach Rule) by taking aim at GoodRx's use of tracking technologies (e.g. pixels) and the sharing of consumer health data for advertising purposes. According to Samuel Levine, director of the FTC's Bureau of Consumer Protection, the FTC \"is serving notice that it will use all of its ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543381+00:00",
              "published_date": null,
              "source_hash": "67805e7483561c8404b88720251f5442"
            },
            {
              "url": "",
              "title": "GoodRx, PBMs accused of suppressing reimbursements to independent ...",
              "snippet": "GoodRx Holdings et al, U.S. District Court for the District of Rhode Island, No. 1:24-cv-00453. For Keaveny Drug: Heidi Silton of Lockridge Grindal Nauen, Bobby Pouya of Pearson Warshaw and others",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543386+00:00",
              "published_date": null,
              "source_hash": "1d1879545cb1c085a971f108c1e0e02e"
            },
            {
              "url": "",
              "title": "GoodRx Agrees to $25 Million Settlement to Resolve Tracking Technology ...",
              "snippet": "GoodRx, a telemedicine platform provider and drug discounter, has agreed to settle a consolidated class action lawsuit for $25 million. The lawsuit was GoodRx has agreed to pay $25 million to resolve a class action lawsuit over its use of website tracking technologies that disclosed users' information to third parties such as Google and Meta Platforms for advertising purposes without their ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543399+00:00",
              "published_date": null,
              "source_hash": "2e5022300885c98078f1fcfc1540b086"
            },
            {
              "url": "",
              "title": "GoodRx Holdings, Inc. - AnnualReports.com",
              "snippet": "GoodRx is a leading resource for healthcare savings and information that makes healthcare affordable and convenient for all Americans. They offer consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:54.543405+00:00",
              "published_date": null,
              "source_hash": "31eeda6607ea88d2790bdfa1a1f948f5"
            },
            {
              "url": "",
              "title": "Hold Rating on GoodRx Holdings Amid Challenges and Opportunities",
              "snippet": "The company's recent financial results were generally in line with expectations, but the future outlook presents some challenges ... GoodRx Holdings (GDRX) Company Description: GoodRx Holdings ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:57.029405+00:00",
              "published_date": "2024-11-11T00:15:00+00:00",
              "source_hash": "7adf66cc54193a1543f8bbcd89cc9db9"
            },
            {
              "url": "",
              "title": "GoodRx Taps Pharmacy Benefits Exec as CEO",
              "snippet": "Santa Monica-based prescription drug savings platform GoodRx Holdings Inc. has hired a pharmacy benefits industry veteran as its next chief executive.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:08.955840+00:00",
              "published_date": "2024-12-30T08:01:00+00:00",
              "source_hash": "2df4dd3e4a4a0b571d0ad12b3ac212b7"
            },
            {
              "url": "",
              "title": "Buy Rating for GoodRx Holdings Amidst Challenges and Growth Prospects",
              "snippet": "Daniel Grosslight has given his Buy rating due to a combination of factors, despite some challenges ... today. GoodRx Holdings (GDRX) Company Description: GoodRx Holdings Inc provides digital ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "retrieved_at": "2025-01-06T14:52:57.029447+00:00",
              "published_date": "2024-11-08T05:49:00+00:00",
              "source_hash": "5373b339a60bb8ce56dbcbc8b2131432"
            },
            {
              "url": "",
              "title": "Goodrx Holdings Inc",
              "snippet": "Drug coupon aggregator GoodRx and pharmacy benefit managers including ... insulin injection for only $35 U.S. healthcare firm GoodRx Holdings has agreed to pay $1.5 million to settle allegations ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:03.126222+00:00",
              "published_date": "2023-12-05T00:00:00+00:00",
              "source_hash": "7ac60e8de6ae7303c641e222992b6748"
            },
            {
              "url": "",
              "title": "GoodRx Holdings, Inc. (NASDAQ:GDRX) Sees Significant Growth in Short Interest",
              "snippet": "GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) was the target of a large increase in short interest during the month of December.As of December 15th, there was short interest totalling ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:08.955822+00:00",
              "published_date": "2025-01-02T00:00:00+00:00",
              "source_hash": "fe44ec9517d275e65d138dd573811d9b"
            },
            {
              "url": "",
              "title": "GoodRx Agrees to Settle Data-Sharing Lawsuit for $25 Million",
              "snippet": "To receive a pro-rated share of the $25 million GoodRx settlement fund, class members will need to file a timely, valid claim form either by mail or through the settlement's official website, which has yet to launch. ClassAction.org will update this page when the official GoodRx settlement website goes live and claim forms can be filed.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417711+00:00",
              "published_date": null,
              "source_hash": "e5ba423fdeb939c2684829a4f0b6e3f1"
            },
            {
              "url": "",
              "title": "GoodRx Settles $25M Class Action Over Health Data Privacy Violati",
              "snippet": "This settlement is separate from the $1.5 million civil penalty GoodRx agreed to as part of the FTC enforcement action, which also prohibits GoodRx from sharing sensitive health data for advertising.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417790+00:00",
              "published_date": null,
              "source_hash": "fe0599376f8f830786dd3cd040490970"
            },
            {
              "url": "",
              "title": "GoodRx hit with fine by feds for sharing users' personal health data ...",
              "snippet": "In a first-of-its-kind enforcement, the Federal Trade Commission has imposed a $1.5 million penalty on telehealth and prescription drug discount provider GoodRx Holdings Inc. for sharing users ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417802+00:00",
              "published_date": null,
              "source_hash": "54beff82a67720f7e1bf3e5bb1507d43"
            },
            {
              "url": "",
              "title": "FTC fines GoodRx for unauthorized sharing of health data",
              "snippet": "Under a settlement, California-based GoodRx also accepted that it will be prohibited going forward from sharing user health data with third parties for advertising purposes, the FTC said. GoodRx admitted no wrongdoing and said in a blog post that it settled \"to avoid the time and expense of protracted litigation.\" The agreement is pending ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417807+00:00",
              "published_date": null,
              "source_hash": "f9f0316acb42ab762bdb9f8e0fc62679"
            },
            {
              "url": "",
              "title": "GoodRx Reaches $25 Million Settlement Over Health Data Sharing ...",
              "snippet": "GoodRx agrees to pay $25M in a class-action settlement over allegations of sharing users' health data with Meta, Google, and Criteo without consent. Health platform settles lawsuit over sharing sensitive user data with Meta, Google & Criteo without consent. Logo (800) 989 ... GoodRx was alleged to have systematically violated user privacy ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417812+00:00",
              "published_date": null,
              "source_hash": "6ceda2bdd03f8204abd1316004eb20ba"
            },
            {
              "url": "",
              "title": "Privacy Tip #356 - GoodRx Settles with FTC for Sharing Health ...",
              "snippet": "The Federal Trade Commission (FTC) announced on February 1, 2023 that it has settled, for $1.5M, its first enforcement action under its Health Breach Notification Rule against GoodRx Holdings, Inc., a telehealth and prescription drug provider.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417817+00:00",
              "published_date": null,
              "source_hash": "01a728eef980d0a7c398eadf75e07b5c"
            },
            {
              "url": "",
              "title": "FTC's GoodRx Enforcement Shows Risks of Improper Data Collection",
              "snippet": "The order prohibits GoodRx from disclosing user health data to third parties for advertising purposes and further assesses a monetary judgment against GoodRx in the amount of $1,500,000.00 for its ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:00.417825+00:00",
              "published_date": null,
              "source_hash": "ebe023ef16960cb7dcfa6fd7f74ab64a"
            },
            {
              "url": "",
              "title": "GoodRx Holdings Inc - Class A",
              "snippet": "GoodRx Holdings Inc provides a platform that helps consumers in the United States save on prescription drugs. By offering a price comparison tool, GoodRx enables users to find the best prices for ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:03.126048+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "0cb25e57a219b0c39115ea4169f0c845"
            },
            {
              "url": "",
              "title": "Geode Capital Management LLC Purchases 58,610 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)",
              "snippet": "According to data from MarketBeat, the stock presently has a consensus rating of \"Moderate Buy\" and a consensus target price of $8.64. GoodRx Holdings, Inc, together with its subsidiaries ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc data privacy concerns and user trust",
              "retrieved_at": "2025-01-06T14:53:03.126177+00:00",
              "published_date": "2025-01-04T00:00:00+00:00",
              "source_hash": "b078bf04eee42381f5c1befc72f0ead2"
            },
            {
              "url": "",
              "title": "GoodRx Holdings Revenue 2018-2024 - Stock Analysis",
              "snippet": "GoodRx Holdings had revenue of $195.25M in the quarter ending September 30, 2024, with 8.50% growth. This brings the company's revenue in the last twelve months to $790.39M, up 7.14% year-over-year. In the year 2023, GoodRx Holdings had annual revenue of $750.27M, down -2.12%.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422436+00:00",
              "published_date": null,
              "source_hash": "d4e10ed74ef65755f2832cc0ae8d9bda"
            },
            {
              "url": "",
              "title": "Breaking Down GoodRx Holdings, Inc. (GDRX) Financial Health: Key ...",
              "snippet": "A Deep Dive into GoodRx Holdings, Inc. (GDRX) Profitability A Deep Dive into GoodRx Holdings, Inc.'s Profitability. Gross Profit Margin: The gross profit margin for the three months ended September 30, 2024, was 94.0%, compared to 89.6% for the same period in 2023. For the nine months ended September 30, 2024, the gross profit margin was 93.9%, an increase from 90.1% in 2023.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422499+00:00",
              "published_date": null,
              "source_hash": "ee11d4003aca60acfe18c2bc39b90c75"
            },
            {
              "url": "",
              "title": "GoodRx Holdings, Inc.",
              "snippet": "GoodRx Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) _____ Delaware 47-5104396 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 2701 Olympic Boulevard Santa Monica, CA 90404 (Address of principal executive offices) (Zip Code) (855) 268-2822",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422512+00:00",
              "published_date": null,
              "source_hash": "b8afa36d792f52025536cdd57f021748"
            },
            {
              "url": "",
              "title": "Goodrx Reports Fourth Quarter and Full Year 2023 Results",
              "snippet": "Revenue and Adjusted Revenue1,2 increased 7% to $196.6 million compared to $184.1 million. Prescription transactions revenue increased 11% to $143.9 million compared to $129.4 million, primarily driven by an 8% increase in Monthly Active Consumers as well as quarter-specific favorability related to certain client contracts.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422521+00:00",
              "published_date": null,
              "source_hash": "75e1ceb39d9b1d258885bcd0fe94d9be"
            },
            {
              "url": "",
              "title": "GDRX | GoodRx Holdings Inc. Financial Statements - WSJ",
              "snippet": "GoodRx Holdings Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View GDRX financial statements in full.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422529+00:00",
              "published_date": null,
              "source_hash": "11c6b38f61203682d725d25758b6ddca"
            },
            {
              "url": "",
              "title": "GoodRx Holdings, Inc. (GDRX) Statistics & Valuation Metrics - Stock ...",
              "snippet": "Detailed statistics for GoodRx Holdings, Inc. (GDRX) stock, including valuation metrics, financial numbers, share information and more. ... GDRX had revenue of $790.39 million and -$16.22 million in losses. Loss per share was -$0.05. Revenue: 790.39M: ... A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score : 2.24 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422538+00:00",
              "published_date": null,
              "source_hash": "c9f4254fe22e25b8b3e21e690a9fead3"
            },
            {
              "url": "",
              "title": "Goodrx Reports Third Quarter 2023 Results",
              "snippet": "GOODRX REPORTS THIRD QUARTER 2023 RESULTS SANTA MONICA, Calif. -- (November 9, 2023) -- GoodRx Holdings, Inc. (Nasdaq: GDRX) (\"GoodRx\" or the \"Company\"), a leading resource for healthcare savings and information, has released its financial results for the third quarter 2023. Third Quarter 2023 Highlights \u2022 Revenue1 of $180.0 million",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422547+00:00",
              "published_date": null,
              "source_hash": "b7444e946bc00b8dc08f7f967ff44a53"
            },
            {
              "url": "",
              "title": "GoodRx Holdings Inc (GDRX) Q2 2024 Earnings Call Highlights: Revenue ...",
              "snippet": "The company achieved an 8% increase in monthly active consumers, contributing to a 7% year-over-year growth in prescription transactions revenue. GoodRx Holdings Inc (NASDAQ:GDRX) has expanded its ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422558+00:00",
              "published_date": null,
              "source_hash": "372855c15787c61516422238807b279f"
            },
            {
              "url": "",
              "title": "GoodRx Holdings Revenue Challenges and Growth ... - Markets Insider",
              "snippet": "In a report released yesterday, Jailendra Singh from Truist Financial maintained a Hold rating on GoodRx Holdings (GDRX \u2013 Research Report)...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422568+00:00",
              "published_date": null,
              "source_hash": "ddff777bd5106e371254bb08aa2429b5"
            },
            {
              "url": "",
              "title": "GoodRx Holdings, Inc. (GDRX) - Yahoo Finance",
              "snippet": "Find out all the key statistics for GoodRx Holdings, Inc. (GDRX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:06.422584+00:00",
              "published_date": null,
              "source_hash": "5e9e49afcfada8743496fcbceab23444"
            },
            {
              "url": "",
              "title": "Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says",
              "snippet": "Wells Fargo upgraded GoodRx Holdings Inc (NASDAQ:GDRX), noting ... there are signs of improved revenue visibility and reduced downside risk. Wells Fargo upgraded GoodRx from Equal Weight to ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:08.955733+00:00",
              "published_date": "2024-03-25T19:13:00+00:00",
              "source_hash": "d04d54883278121464ad6b1ea49595de"
            },
            {
              "url": "",
              "title": "GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates",
              "snippet": "GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings ... The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:08.955811+00:00",
              "published_date": "2024-11-07T13:35:00+00:00",
              "source_hash": "87c34b3843184f1bf6f21dc5bf3a22e0"
            },
            {
              "url": "",
              "title": "Is GoodRx Holdings (GDRX) the Best NASDAQ Penny Stock to Buy Right Now?",
              "snippet": "In this article, we are going to look at where GoodRx Holdings, Inc. (NASDAQ:GDRX ... the $1 per share minimum share price thresholds, revenue standards, and market capitalization thresholds.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Goodrx Holdings Inc GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "retrieved_at": "2025-01-06T14:53:08.955831+00:00",
              "published_date": "2024-12-11T02:04:00+00:00",
              "source_hash": "56accc815e7928b60cebbb0b8ecb4c57"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "GoodRx Holdings Inc regulatory scrutiny and legal challenges",
              "rationale": "Investigate potential legal and regulatory risks, including data privacy and advertising practices",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "GoodRx Holdings Inc data privacy concerns and user trust",
              "rationale": "Examine controversies related to the collection, storage, and sharing of sensitive healthcare data",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "GoodRx Holdings Inc revenue concentration risks and advertising dependency",
              "rationale": "Assess vulnerabilities due to reliance on advertising revenue and potential impacts from regulatory changes",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T07:53:27.966247",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}